nifedipine has been researched along with 1,6-bis(cyclohexyloximinocarbonyl)hexane in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coats, P; Hillier, C; Johnston, F; MacDonald, J; McMurray, JJ | 1 |
Gscheidlinger, R; Hohenegger, M; Karel, A; Weigl, L; Zidar, A | 1 |
2 other study(ies) available for nifedipine and 1,6-bis(cyclohexyloximinocarbonyl)hexane
Article | Year |
---|---|
Signalling mechanisms underlying the myogenic response in human subcutaneous resistance arteries.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Aged; Analysis of Variance; Arteries; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium-Transporting ATPases; Cyclohexanones; Enzyme Inhibitors; Estrenes; Female; Humans; In Vitro Techniques; Indoles; Lipoprotein Lipase; Male; Middle Aged; Muscle, Smooth, Vascular; Naphthalenes; Nifedipine; Phorbol 12,13-Dibutyrate; Protein Kinase C; Pyrrolidinones; Ryanodine; Ryanodine Receptor Calcium Release Channel; Signal Transduction; Type C Phospholipases; Vascular Resistance | 2001 |
Store operated Ca2+ influx by selective depletion of ryanodine sensitive Ca2+ pools in primary human skeletal muscle cells.
Topics: Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Cyclohexanones; Diglycerides; Humans; Lipoprotein Lipase; Magnesium; Muscle Cells; Muscle, Skeletal; Nifedipine; Protein Kinase C; Reverse Transcriptase Polymerase Chain Reaction; Ryanodine; Ryanodine Receptor Calcium Release Channel; Time Factors; Type C Phospholipases | 2003 |